Vapiprost hydrochloride

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameVapiprost hydrochloride
Drug Alias Namevapiprost (free)GR-32191BGR-32191(free)SN-309
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThromboxane A2 receptor antagonists
TargetsThromboxane A2 receptor
Therapy Area/IndicationsVenous ThrombosisCoronary RestenosisMyocardial Ischemia +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsVenous ThrombosisCoronary RestenosisMyocardial Ischemia +[4
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A